Fc-Modified Antibody in Hospitalized Severe COVID-19 Patients.
Saved in:
| Title: | Fc-Modified Antibody in Hospitalized Severe COVID-19 Patients. |
|---|---|
| Authors: | Dal-Pizzol F; Intensive Care Unit, Hospital São José, Criciúma 88806-000, SC, Brazil.; Laboratory of Experimental Pathophysiology, Graduate Program in Health Sciences, Universidade do Extremo Sul Catarinense, Criciúma 88806-000, SC, Brazil., Lobo SM; Intensive Care Division, Hospital de Base, FAMERP, São José do Rio Preto 15090-000, SP, Brazil., Lucasti C; South Jersey Infectious Disease, 730 Shore Road, Somers Point 08244, NJ, USA., Baidoo AAH; Beijing Engineering Research Center of Protein and Antibody, Sinocelltech Ltd., Beijing 100176, China., Su H; Beijing Engineering Research Center of Protein and Antibody, Sinocelltech Ltd., Beijing 100176, China., Lan Z; Beijing Engineering Research Center of Protein and Antibody, Sinocelltech Ltd., Beijing 100176, China., Xie L; Beijing Engineering Research Center of Protein and Antibody, Sinocelltech Ltd., Beijing 100176, China.; Cell Culture Engineering Center, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100005, China. |
| Source: | Vaccines [Vaccines (Basel)] 2025 Mar 31; Vol. 13 (4). Date of Electronic Publication: 2025 Mar 31. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101629355 Publication Model: Electronic Cited Medium: Print ISSN: 2076-393X (Print) Linking ISSN: 2076393X NLM ISO Abbreviation: Vaccines (Basel) Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2076-393X |
|---|---|
| DOI: | 10.3390/vaccines13040372 |
